Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma

<p>Abstract</p> <p>Background</p> <p>Nasopharyngeal carcinoma (NPC) is a type of neoplasm that is highly prevalent in East Asia and Africa with Epstein-Barr virus (EBV), genetic, and dietary factors implicated as possible aetiologic factors. Previous studies suggested t...

Full description

Bibliographic Details
Main Authors:	Khoo Alan SB, Gan Sook-Yee, Chew Michelle MS, Tan Eng-Lai
Format:	Article
Language:	English
Published:	BMC 2010-10-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/574

Similar Items

Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
by: Pok Man Hau, et al.
Published: (2011-01-01)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
by: Naveed Ahmed, et al.
Published: (2022-12-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

Detection of epstein - barr virus (EBV) in nasopharyngeal cancer.
by: Seow, Heng Fong
Published: (2007)

Hubungan virus Epstein Barr dengan penyakit hodgkin :: Suatu analisis imunohistopatologik ekspresi EBV LMP-1
by: , MURTONO, C, et al.
Published: (1996)

Hubungan virus Epstein Barr dengan penyakit hodgkin :: Suatu analisis imunohistopatologik ekspresi EBV LMP-1
by: , MURTONO, C, et al.
Published: (1996)

Hubungan antara virus Epstein Barr dengan penyakit Hodgkin. Suatu analisis imunohistopatologik ekspresi EBV LMP-1.
by: Perpustakaan UGM, i-lib
Published: (1997)

Latent Membrane Protein 1 (LMP1) from Epstein–Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells
by: Barbara G. Müller Coan, et al.
Published: (2022-02-01)

Effect of epstein-barr virus (EBV) encoded latent membrane protein-1 (30 bp deletion mutant) on immune checkpoint regulation in nasopharyngeal and ebv-associated non-nasopharyngeal cancers
by: Ahmed, Naveed
Published: (2024)

Epstein-Barr Virus Latent Membrane Protein 1 (Lmp-1) Expression And Its Association With Expression Of Dna Damage Repair Proteins In Nasopharyngeal Carcinoma (Npc) – An Evaluation
by: Yu, Wei Chiuen
Published: (2013)

Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas
by: Jing Yongzheng, et al.
Published: (2010-11-01)

Epstein–Barr virus (Orthoherpesviridae: <i>Lymphocryptovirus</i>) among Russian ethnic groups: Prevalence of EBV types (EBV-1 and EBV-2), <i>LMP1</i> gene variants and malignancies
by: Vladimir E. Gurtsevitch, et al.
Published: (2024-03-01)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
by: Mujeeb Cheerathodi, et al.
Published: (2021-04-01)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
by: Abdelhalim Khenchouche, et al.
Published: (2023-06-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
by: ستار عبود فارس, et al.
Published: (2019-05-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
by: ستار عبود فارس, et al.
Published: (2019-05-01)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
by: Valerie E. Salano, et al.
Published: (2021-12-01)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
by: Kathy H. Y. Shair, et al.
Published: (2012-11-01)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
by: Lun-Quan Sun, et al.
Published: (2010-09-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
by: Saidu Kamara, et al.
Published: (2023-06-01)

Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway
by: Husaini Roslina, et al.
Published: (2011-12-01)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
by: Haifeng Huo, et al.
Published: (2019-10-01)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
by: Chung-Chun Wu, et al.
Published: (2018-04-01)

Establishment of Epstein–Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
by: Hiroyuki Kanno, et al.
Published: (2023-10-01)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
by: Cua Thi Hong Trinh, et al.
Published: (2023-01-01)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
by: Wilson Joanna B, et al.
Published: (2010-07-01)

Variansi sekuen gen penyandi C terminus latent membrane protein 1 (LMP-1) epstein-barr virus penderita karsinoma nasofaring
by: , HARYANTO, Aris, et al.
Published: (1999)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
by: Racha Bahri, et al.
Published: (2022-06-01)

Genotypic and functional comparisons of Epstein-barr virus latent membrane protein-1 from different stages of nasopharyngeal carcinoma
by: Tan, Eng Lai, et al.
Published: (2004)

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma
by: Qi Yuan, et al.
Published: (2023-07-01)

EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma
by: San Xu, et al.
Published: (2021-04-01)

Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes
by: Y.L. Tang, et al.
Published: (2008-02-01)

The Expression of mRNA LMP1 Epstein-Barr Virus from FFPE Tumour Biopsy: a Potential Biomarker of Nasopharyngeal Carcinoma Diagnosis
by: Daniel Joko Wahyono, et al.
Published: (2017-07-01)

New Look of EBV LMP1 Signaling Landscape
by: Ling Wang, et al.
Published: (2021-10-01)

Phylodynamic characteristics of the LMP-1 gene of the Epstein–Barr virus isolated in the Nizhny Novgorod region
by: Daria A. Bryzgalova, et al.
Published: (2023-11-01)

Epstein–Barr virus in the ethnic Tatars population: the infection and sequence variants of LMP1 oncogene
by: K. V. Smirnova, et al.
Published: (2018-11-01)

Vaccination of Tamarin with Recombinant Vaccinia Virus Expressing Epstein Barr Virus (EBV) Latent Proteins
by: Mahmood Mahmoodian Shooshtari, et al.
Published: (2004-06-01)

Radiation-induced Epstein–Barr virus reactivation in gastric cancer cells with latent EBV infection
by: Athira Nandakumar, et al.
Published: (2017-06-01)